NCT01137461

Brief Summary

The objective of this study is to evaluate the efficacy of embryo transfer procedure guided by transvaginal ultrasound versus abdominal ultrasound in recipients of oocytes as well as the advantages and disadvantages of the new technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
330

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jun 2010

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 3, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 4, 2010

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
Last Updated

April 14, 2011

Status Verified

April 1, 2011

Enrollment Period

4 months

First QC Date

June 3, 2010

Last Update Submit

April 13, 2011

Conditions

Keywords

Female infertility with indication of oocyte reception

Outcome Measures

Primary Outcomes (1)

  • Clinical pregnancy rate

    Evidence of gestational sac by transvaginal ultrasound

    40 days after embryo transfer

Study Arms (2)

abdominal ultrasound

OTHER

traditional technique

Procedure: ultrasound-guided embryo transfer

transvaginal ultrasound

OTHER

new technique

Procedure: ultrasound-guided embryo transfer

Interventions

Embryo transfer in oocyte recipients

abdominal ultrasoundtransvaginal ultrasound

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Oocyte recipients.
  • Uterus without previously detected anomalies.
  • Patients able to understand the study requirements who want to participate during all its duration and that have signed the informed consent.

You may not qualify if:

  • Turner syndrome, Black race (significantly lower implantational rates)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinica EUGIN

Barcelona, Barcelona, 08029, Spain

Location

Related Publications (1)

  • Bodri D, Colodron M, Garcia D, Obradors A, Vernaeve V, Coll O. Transvaginal versus transabdominal ultrasound guidance for embryo transfer in donor oocyte recipients: a randomized clinical trial. Fertil Steril. 2011 Jun;95(7):2263-8, 2268.e1. doi: 10.1016/j.fertnstert.2011.03.028. Epub 2011 Apr 2.

Related Links

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Daniel Bodri

    Clinica EUGIN

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 3, 2010

First Posted

June 4, 2010

Study Start

June 1, 2010

Primary Completion

October 1, 2010

Study Completion

October 1, 2010

Last Updated

April 14, 2011

Record last verified: 2011-04

Locations